Tshiab Japanese Patent ntawm Ovarian Cancer Vaccine

"Peb txaus siab tshaj tawm qhov kev tiv thaiv kev txawj ntse ntxiv ntawm Anixa cov tshuaj tiv thaiv kab mob qog noj ntshav tshiab, uas tau tsim los ntawm Cleveland Clinic thiab tab tom kawm ntawm NCI. Cov cuab yeej tshwj xeeb no muaj peev xwm los ua thawj cov tshuaj tiv thaiv kab mob qog noj ntshav ntawm zes qe menyuam, uas tseem yog ib qho mob qog noj ntshav uas mob hnyav tshaj plaws thiab kho tau nyuaj, "said Dr. Amit Kumar, CEO, Thawj Tswj Hwm thiab Thawj Tswj Hwm ntawm Anixa Biosciences. "Yog tias ua tiav, cov tshuaj tiv thaiv no tuaj yeem tiv thaiv kab mob qog noj ntshav ntawm zes qe menyuam tsis tau tshwm sim thiab tso cov neeg mob los ntawm kev siv tshuaj khomob thiab kev kho mob phais ntau, thiab muaj peev xwm cawm tau txoj sia. Peb tos ntsoov yuav txuas ntxiv peb txoj haujlwm kho mob nyob rau hauv kev cia siab tias cov tshuaj tiv thaiv no yuav ntxiv rau lub arsenal xav tau los tsom rau qhov mob qog noj ntshav nyuaj no thiab thaum kawg ua qhov sib txawv rau ntau tus neeg mob. "

Cov tshuaj tiv thaiv kab mob qog noj ntshav ntawm zes qe menyuam yog tsom rau qhov chaw ntxiv ntawm cov tshuaj tiv thaiv-Müllerian hormone receptor 2 (AMHR2-ED), uas tau nthuav tawm hauv zes qe menyuam tab sis ploj mus thaum tus poj niam nce mus txog thiab nce mus txog thaum cev xeeb tub. Ntawm qhov kev ceeb toom, feem ntau ntawm kev kuaj mob qog noj ntshav zes qe menyuam tshwm sim tom qab lub cev tsis muaj zog, thiab AMHR2-ED tau qhia dua rau feem ntau ntawm cov qog nqaij hlav zes qe menyuam. Los ntawm kev tau txais cov tshuaj tiv thaiv xws li Anixa's lub hom phiaj AMHR2-ED tom qab ncav cuag poj niam cev xeeb tub, mob qog noj ntshav ntawm zes qe menyuam, keeb kwm yog ib qho mob qog noj ntshav hauv gynecological, tuaj yeem tiv thaiv kom tsis txhob muaj kev loj hlob.

Kev ua haujlwm kho mob ua ntej txhawm rau txhawm rau txhawm rau txhaj tshuaj tiv thaiv tau txuas ntxiv los ntawm PREVENT Program ntawm National Cancer Institute (NCI), uas txhawb nqa cov kev pab cuam kho mob tshiab thiab biomarkers rau kev tiv thaiv kab mob qog noj ntshav thiab cuam tshuam. Cov ntaub ntawv Preclinical luam tawm hauv Kev Tshawb Fawb Kev Tiv Thaiv Kab Mob hauv xyoo 2017 txhawb kev nce qib mus rau kev tshawb fawb soj ntsuam.

Print Friendly, PDF & Email

Xov Xwm Lwm Yam